CD274 and urinary bladder carcinoma: Preliminary analysis has indicated a link between molecular subtypes of bladder cancer and response to PD-L1 inhibition, where patients with luminal tumours showed better response to PD-L1 inhibition44 pinpointing the importance of performing multi-regional subtyping.